Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001227825 | SCV001400201 | likely benign | Gorlin syndrome | 2024-02-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003294091 | SCV003994244 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-03-31 | criteria provided, single submitter | clinical testing | The p.H328L variant (also known as c.983A>T), located in coding exon 7 of the PTCH1 gene, results from an A to T substitution at nucleotide position 983. The histidine at codon 328 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |